Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

416 ARTÍCULOS , VIENDO DEL 151 AL 165

[Corneal perforation due to 'lost' contact lenses]

Floor T, Henry YP, Kraal-Biezen E.

Ned Tijdschr Geneeskd. 2019 Oct 17;163:D4177.

Nanoparticle-mediated approaches for Alzheimer's disease pathogenesis, diagnosis, and therapeutics

Hettiarachchi SD, Zhou Y, Seven E, Lakshmana MK, Kaushik AK, Chand HS, Leblanc RM.

J Control Release. 2019 Nov 28;314:125-140. doi: 10.1016/j.jconrel.2019.10.034. Epub 2019 Oct 21.

Strategies Targeting Soluble β-Amyloid Oligomers and their Application to Early Diagnosis of Alzheimer's Disease

Zeng F, Li Y, Xu Y, Yang J, Liu Z, Li X, Ren L.

Curr Alzheimer Res. 2019;16(12):1132-1142. doi: 10.2174/1567205016666191031163504.

Extracellular vesicles as an emerging tool for the early detection of Alzheimer's disease

Li TR, Wang XN, Sheng C, Li YX, Li FZ, Sun Y, Han Y.

Mech Ageing Dev. 2019 Dec;184:111175. doi: 10.1016/j.mad.2019.111175. Epub 2019 Nov 1.

Randomized, Placebo Controlled Trial of NPT088, A Phage-Derived, Amyloid-Targeted Treatment for Alzheimer's Disease

Michelson D, Grundman M, Magnuson K, Fisher R, Levenson JM, Aisen P, Marek K, Gray M, Hefti F.

J Prev Alzheimers Dis. 2019;6(4):228-231. doi: 10.14283/jpad.2019.37.

Utilization, effect, and benefit of the individualized Meeting Centers Support Program for people with dementia and caregivers

Dröes RM, van Rijn A, Rus E, Dacier S, Meiland F.

Clin Interv Aging. 2019 Aug 26;14:1527-1553. doi: 10.2147/CIA.S212852. eCollection 2019.

Identification and Management of Insomnia in Alzheimer's Disease

Roth T, Brunton S.

J Fam Pract. 2019 Oct;68(8):S32-S38.

Tracking down a missing trigger for Alzheimer's disease by mass spectrometric imaging based on brain network analysis

Hoshi M.

Prog Mol Biol Transl Sci. 2019;168:25-55. doi: 10.1016/bs.pmbts.2019.05.011. Epub 2019 Jul 27.

Rare case offers clues to staving off Alzheimer's

Servick K.

Science. 2019 Nov 8;366(6466):674. doi: 10.1126/science.366.6466.674.

No MMSE for You! A Case of an "Uncooperative" Patient With Early-Onset Dementia

Tsai PH, Kaur G, Gopalakrishna G.

Prim Care Companion CNS Disord. 2019 Oct 24;21(5):19alz02544. doi: 10.4088/PCC.19alz02544.

Different aspects of Alzheimer's disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia

Thal DR, Ronisz A, Tousseyn T, Rijal Upadhaya A, Balakrishnan K, Vandenberghe R, Vandenbulcke M, von Arnim CAF, Otto M, Beach TG, Lilja J, Heurling K, Chakrabarty A, Ismail A, Buckley C, Smith APL, Kumar S, Farrar G, Walter J.

Acta Neuropathol Commun. 2019 Nov 14;7(1):178. doi: 10.1186/s40478-019-0837-9.

Sixteen-Week Interventional Study to Evaluate the Clinical Effects and Safety of Rivastigmine Capsules in Chinese Patients with Alzheimer's Disease

Jia J, Ji Y, Feng T, Ye Q, Peng D, Kuang W, Ning Y, Liang Z, Fan D, Wei W, Li Y, Xiao S.

J Alzheimers Dis. 2019;72(4):1313-1322. doi: 10.3233/JAD-190791.

Hyperinsulinemia or Insulin Resistance: What Impacts the Progression of Alzheimer's Disease?

Hegde V, Dhurandhar NV, Reddy PH.

J Alzheimers Dis. 2019;72(s1):S71-S79. doi: 10.3233/JAD-190808.

Alzheimer's disease

Soria Lopez JA, González HM, Léger GC.

Handb Clin Neurol. 2019;167:231-255. doi: 10.1016/B978-0-12-804766-8.00013-3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias